Trial number | Treatment | Tumor | status | Estimated completion | Sponsor/Institution |
---|---|---|---|---|---|
NCT01219348 | peptide2 | NSCLC3 | recruiting | June 2012 | Herlev Hospital, Copenhagen, Denmark |
NCT01685255 | INCB0243604 | Ovarian cancer | recruiting | Nov 2015 | Incyte Corporation, Wilmington, DE |
NCT01543464 | peptide2 | melanoma | recruiting | Sept 2014 | Herlev Hospital, Copenhagen, Denmark |
NCT00739609 | 1-methyl-D-tryptophan5 | Various solid tumors | terminated | Oct 2012 | Vanderbilt University, Nashville, TN and New Link Genetics Corporation, Ames, IA |
NCT00567931 | 1-methyl-D-tryptophan5 | Various solid tumors | recruiting | undefined | Lee Moffit Cancer Center, Tampa, FL and Virginia Commonwealth University, Richmond, VA. |
NCT01604889 | INCB0243604 | melanoma | recruiting | Feb 2015 | Various locations, Incyte Corporation, Wilmington, DE |
NCT01195311 | INCB0243604 | Various solid tumors | Active, recruiting | Mar 2013 | Incyte Corporation, Wilmington, DE |